Skip to content
OpenCapital
Get started

Kiora Pharmaceuticals, Inc. KPRX Q4 2024 Annual earnings

Reported March 25, 2025 · Before market open

EPS-$1.04Miss by $0.40
Revenue estimate$750.0K
EPS estimate-$0.64

Next report

Aug 7, 2026 (In 1 week)
EPS estimate-$0.47

Versus estimates

Diluted EPS

Q1 2026-$0.58In lineQ4 2025-$1.60Miss by $0.93Q3 2025$0.01Beat by $0.73Q2 2025-$0.54Beat by $0.04Q1 2025-$0.52Beat by $0.25
Q4 2024-$1.04Miss by $0.40

Ask the moment Kiora Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kiora Pharmaceuticals, Inc. report Q4 2024 earnings?
Kiora Pharmaceuticals, Inc. (KPRX) reported Q4 2024 earnings on March 25, 2025 before market open.
What were Kiora Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Kiora Pharmaceuticals, Inc. reported eps of $-1.04 for Q4 2024.
Did Kiora Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.64 by $0.40.
Where can I find Kiora Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001372514-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.